GlaxoSmithKline (CAI:BIOC) Days Payable: 217.68 (As of Sep. 2016)


What is GlaxoSmithKline Days Payable?

GlaxoSmithKline CAI:BIOC +0.49% Days Payable is 217.68 as of Sep. 2016.

GlaxoSmithKline's average Accounts Payable for the three months ended in Sep. 2016 was E£232 Mil. GlaxoSmithKline's Cost of Goods Sold for the three months ended in Sep. 2016 was E£97 Mil. Hence, GlaxoSmithKline's Days Payable for the three months ended in Sep. 2016 was 217.68.

The historical rank and industry rank for GlaxoSmithKline's Days Payable or its related term are showing as below:

CAI:BIOC's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 90.455
* Ranked among companies with meaningful Days Payable only.

GlaxoSmithKline's Days Payable increased from Sep. 2015 (89.62) to Sep. 2016 (217.68). It may suggest that GlaxoSmithKline delayed paying its suppliers.

GlaxoSmithKline Days Payable Historical Data

* Premium members only.

The historical data trend for GlaxoSmithKline's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline Days Payable Chart

GlaxoSmithKline Annual Data
Trend Dec12 Dec13 Dec14 Dec15
Days Payable
88.32 85.22 85.74 105.56

GlaxoSmithKline Quarterly Data
Dec12 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.62 811.56 87.76 81.60 217.68

CAI:BIOC vs PRPH: Days Payable Comparison

For the Drug Manufacturers - General subindustry, GlaxoSmithKline's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline's Days Payable distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline's Days Payable falls into.


GlaxoSmithKline Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

GlaxoSmithKline's Days Payable for the fiscal year that ended in Dec. 2015 is calculated as

Days Payable (A: Dec. 2015 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2014 ) + Accounts Payable (A: Dec. 2015 )) / count ) / Cost of Goods Sold (A: Dec. 2015 )*Days in Period
=( (168.115 + 210.627) / 2 ) / 654.824*365
=189.371 / 654.824*365
=105.56

GlaxoSmithKline's Days Payable for the quarter that ended in Sep. 2016 is calculated as:

Days Payable (Q: Sep. 2016 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2016 ) + Accounts Payable (Q: Sep. 2016 )) / count ) / Cost of Goods Sold (Q: Sep. 2016 )*Days in Period
=( (240.645 + 222.777) / 2 ) / 97.132*365 / 4
=231.711 / 97.132*365 / 4
=217.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 217.68 mean?
GlaxoSmithKline (CAI:BIOC) has a Days Payable of 217.68 as of Sep. 2016. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on GlaxoSmithKline and its competitors.
Is GlaxoSmithKline's Days Payable too high?
GlaxoSmithKline's current Days Payable is 217.68. The Drug Manufacturers industry median Days Payable is 90.46. GlaxoSmithKline's value of 217.68 is 140.7% above this industry median.
How does GlaxoSmithKline's Days Payable compare to PRPH?
GlaxoSmithKline's Days Payable of 217.68 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.46. GlaxoSmithKline's value of 217.68 is 140.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.46, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GlaxoSmithKline's current Days Payable of 217.68 is 140.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on GlaxoSmithKline and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GlaxoSmithKline's current Days Payable is 217.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlaxoSmithKline stock overvalued right now?
GlaxoSmithKline (CAI:BIOC) has a current Days Payable of 217.68. The current Days Payable is 217.68 and 140.7% above the Drug Manufacturers industry median of 90.46. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For GlaxoSmithKline (CAI:BIOC), the current Days Payable is 217.68 as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlaxoSmithKline Business Description

Address Boomerang Building, No 46, Block (J) First Section City Centre, Town Centre, Second floor, Fifth District - New Cairo, Cairo, EGY, 11835
GlaxoSmithKline is a pharmaceutical company. It is focused on developing new medicines in respiratory, HIV, oncology, and immune-inflation. The company is segmented into Commercial Operations and Total Research and development. It generates the majority of its revenue from the Commercial Operations segment.